Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 3 | 2023 | 61 | 2.120 |
Why?
|
Myocardial Infarction | 2 | 2021 | 225 | 1.230 |
Why?
|
Diabetes, Gestational | 2 | 2023 | 47 | 1.070 |
Why?
|
Particulate Matter | 2 | 2017 | 51 | 1.040 |
Why?
|
Quality of Life | 2 | 2019 | 481 | 0.990 |
Why?
|
Florida | 11 | 2023 | 410 | 0.950 |
Why?
|
Mass Screening | 2 | 2019 | 462 | 0.940 |
Why?
|
Pregnancy | 11 | 2023 | 1549 | 0.930 |
Why?
|
Environmental Exposure | 2 | 2017 | 216 | 0.920 |
Why?
|
Uterine Rupture | 1 | 2023 | 4 | 0.920 |
Why?
|
Risk Factors | 14 | 2023 | 3562 | 0.900 |
Why?
|
HIV Infections | 8 | 2021 | 2303 | 0.870 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 664 | 0.860 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2022 | 18 | 0.840 |
Why?
|
Premature Birth | 1 | 2023 | 75 | 0.830 |
Why?
|
Pregnancy Complications | 1 | 2023 | 126 | 0.820 |
Why?
|
Bayes Theorem | 3 | 2023 | 94 | 0.810 |
Why?
|
Bronchitis, Chronic | 1 | 2021 | 15 | 0.800 |
Why?
|
Kidney Failure, Chronic | 2 | 2019 | 233 | 0.710 |
Why?
|
Viral Load | 3 | 2020 | 312 | 0.710 |
Why?
|
Pregnancy Trimester, First | 2 | 2017 | 17 | 0.710 |
Why?
|
Aluminum | 2 | 2017 | 36 | 0.710 |
Why?
|
Peritoneal Dialysis | 1 | 2019 | 9 | 0.680 |
Why?
|
Humans | 39 | 2023 | 37093 | 0.670 |
Why?
|
Female | 27 | 2023 | 20969 | 0.670 |
Why?
|
Carbon | 2 | 2017 | 105 | 0.650 |
Why?
|
Pregnant Women | 1 | 2019 | 48 | 0.640 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2019 | 72 | 0.640 |
Why?
|
Models, Statistical | 2 | 2016 | 180 | 0.630 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 485 | 0.630 |
Why?
|
Lead | 1 | 2019 | 93 | 0.620 |
Why?
|
Renal Dialysis | 1 | 2019 | 120 | 0.620 |
Why?
|
Adult | 18 | 2023 | 11712 | 0.610 |
Why?
|
Impulsive Behavior | 1 | 2018 | 46 | 0.610 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 103 | 0.600 |
Why?
|
Abruptio Placentae | 1 | 2017 | 1 | 0.590 |
Why?
|
Young Adult | 12 | 2023 | 4268 | 0.580 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 149 | 0.570 |
Why?
|
Enterobacteriaceae Infections | 3 | 2021 | 11 | 0.570 |
Why?
|
Adolescent | 16 | 2022 | 5363 | 0.540 |
Why?
|
Stroke | 1 | 2019 | 286 | 0.520 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 204 | 0.520 |
Why?
|
Infant Mortality | 2 | 2012 | 55 | 0.510 |
Why?
|
Pregnancy Trimesters | 1 | 2014 | 14 | 0.510 |
Why?
|
Income | 1 | 2016 | 140 | 0.500 |
Why?
|
Infant, Newborn | 5 | 2023 | 894 | 0.500 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2016 | 215 | 0.490 |
Why?
|
Health Behavior | 1 | 2019 | 537 | 0.490 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 282 | 0.480 |
Why?
|
Social Class | 1 | 2016 | 247 | 0.460 |
Why?
|
Feeding Behavior | 1 | 2018 | 454 | 0.460 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 39 | 0.440 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 2721 | 0.440 |
Why?
|
After-Hours Care | 1 | 2012 | 5 | 0.430 |
Why?
|
Exercise | 1 | 2018 | 613 | 0.410 |
Why?
|
Air Pollution, Indoor | 2 | 2021 | 41 | 0.370 |
Why?
|
Odds Ratio | 3 | 2017 | 534 | 0.360 |
Why?
|
Middle Aged | 9 | 2020 | 10129 | 0.360 |
Why?
|
Prevalence | 5 | 2022 | 1455 | 0.350 |
Why?
|
Kuwait | 2 | 2019 | 4 | 0.340 |
Why?
|
Obesity | 2 | 2021 | 1067 | 0.330 |
Why?
|
Hypertension | 1 | 2016 | 796 | 0.320 |
Why?
|
Retrospective Studies | 7 | 2023 | 2026 | 0.320 |
Why?
|
Male | 15 | 2020 | 20025 | 0.300 |
Why?
|
United States | 7 | 2023 | 4223 | 0.290 |
Why?
|
Anti-HIV Agents | 2 | 2020 | 420 | 0.260 |
Why?
|
Gestational Age | 2 | 2022 | 190 | 0.250 |
Why?
|
Hysterectomy | 1 | 2023 | 28 | 0.230 |
Why?
|
Nutrition Surveys | 2 | 2021 | 242 | 0.230 |
Why?
|
Incidence | 2 | 2017 | 922 | 0.220 |
Why?
|
Educational Status | 2 | 2016 | 313 | 0.210 |
Why?
|
Aged | 3 | 2019 | 6741 | 0.210 |
Why?
|
Cadmium | 1 | 2021 | 58 | 0.200 |
Why?
|
Hypersensitivity | 1 | 2021 | 30 | 0.190 |
Why?
|
Age Distribution | 2 | 2019 | 225 | 0.190 |
Why?
|
Gonorrhea | 1 | 2021 | 24 | 0.190 |
Why?
|
Chlamydia | 1 | 2021 | 42 | 0.190 |
Why?
|
Malnutrition | 1 | 2021 | 44 | 0.190 |
Why?
|
Bangladesh | 2 | 2021 | 20 | 0.190 |
Why?
|
Prospective Studies | 2 | 2021 | 1378 | 0.180 |
Why?
|
Cannabis | 1 | 2022 | 79 | 0.180 |
Why?
|
Triage | 1 | 2020 | 26 | 0.180 |
Why?
|
Cross Infection | 1 | 2020 | 38 | 0.180 |
Why?
|
Intention | 1 | 2020 | 94 | 0.170 |
Why?
|
Fetal Blood | 1 | 2019 | 50 | 0.170 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 109 | 0.170 |
Why?
|
Models, Theoretical | 1 | 2020 | 217 | 0.170 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 94 | 0.170 |
Why?
|
Telomere | 1 | 2019 | 56 | 0.160 |
Why?
|
Risk-Taking | 2 | 2020 | 451 | 0.160 |
Why?
|
Self Efficacy | 1 | 2020 | 184 | 0.160 |
Why?
|
Employment | 1 | 2019 | 76 | 0.160 |
Why?
|
Vaccination | 1 | 2020 | 288 | 0.160 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 137 | 0.160 |
Why?
|
Linear Models | 1 | 2019 | 275 | 0.160 |
Why?
|
Patient Compliance | 1 | 2020 | 212 | 0.160 |
Why?
|
Child | 4 | 2020 | 3131 | 0.150 |
Why?
|
Overweight | 2 | 2021 | 247 | 0.150 |
Why?
|
Infant | 3 | 2021 | 1046 | 0.150 |
Why?
|
Sexual Behavior | 2 | 2020 | 609 | 0.140 |
Why?
|
Smoking Cessation | 1 | 2023 | 517 | 0.140 |
Why?
|
Drug Resistance, Viral | 1 | 2016 | 63 | 0.140 |
Why?
|
beta-Lactamases | 3 | 2021 | 33 | 0.140 |
Why?
|
Cognition | 1 | 2020 | 398 | 0.140 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 39 | 0.140 |
Why?
|
Papillomavirus Vaccines | 1 | 2018 | 151 | 0.130 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 730 | 0.130 |
Why?
|
Cesarean Section | 2 | 2012 | 55 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 864 | 0.130 |
Why?
|
Parents | 1 | 2018 | 329 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 194 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2018 | 277 | 0.120 |
Why?
|
Sodium | 1 | 2014 | 103 | 0.120 |
Why?
|
Potassium | 1 | 2014 | 112 | 0.120 |
Why?
|
Magnesium | 1 | 2014 | 97 | 0.120 |
Why?
|
Multivariate Analysis | 1 | 2016 | 583 | 0.120 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 336 | 0.120 |
Why?
|
Urban Population | 1 | 2016 | 333 | 0.120 |
Why?
|
Smoking | 3 | 2020 | 940 | 0.110 |
Why?
|
Rural Population | 1 | 2016 | 294 | 0.110 |
Why?
|
Sex Factors | 2 | 2016 | 898 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 284 | 0.110 |
Why?
|
Aged, 80 and over | 1 | 2019 | 2379 | 0.110 |
Why?
|
Iron | 1 | 2014 | 225 | 0.110 |
Why?
|
Logistic Models | 1 | 2016 | 923 | 0.110 |
Why?
|
Marital Status | 1 | 2012 | 40 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2012 | 149 | 0.100 |
Why?
|
Delivery, Obstetric | 1 | 2012 | 40 | 0.100 |
Why?
|
Asthma | 1 | 2015 | 380 | 0.100 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 441 | 0.100 |
Why?
|
Time Factors | 2 | 2012 | 1742 | 0.090 |
Why?
|
Fetal Death | 1 | 2010 | 18 | 0.090 |
Why?
|
Twins | 1 | 2010 | 17 | 0.090 |
Why?
|
Fetal Development | 1 | 2010 | 29 | 0.090 |
Why?
|
India | 2 | 2020 | 88 | 0.090 |
Why?
|
Age Factors | 1 | 2012 | 1033 | 0.080 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 1067 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 352 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2021 | 540 | 0.070 |
Why?
|
Child, Preschool | 2 | 2021 | 1418 | 0.060 |
Why?
|
Health Expenditures | 1 | 2023 | 32 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2014 | 1502 | 0.050 |
Why?
|
Fetal Macrosomia | 1 | 2021 | 12 | 0.050 |
Why?
|
Cats | 1 | 2021 | 69 | 0.050 |
Why?
|
Birth Weight | 1 | 2021 | 90 | 0.050 |
Why?
|
Biomass | 1 | 2021 | 54 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2021 | 59 | 0.050 |
Why?
|
Dogs | 1 | 2021 | 149 | 0.050 |
Why?
|
Allergens | 1 | 2021 | 63 | 0.050 |
Why?
|
Dust | 1 | 2021 | 54 | 0.050 |
Why?
|
Weight Gain | 1 | 2021 | 136 | 0.050 |
Why?
|
Carbapenems | 1 | 2020 | 8 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2020 | 75 | 0.050 |
Why?
|
Enterobacteriaceae | 1 | 2020 | 28 | 0.040 |
Why?
|
Health Status | 1 | 2023 | 380 | 0.040 |
Why?
|
Hospitals | 1 | 2020 | 86 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2019 | 66 | 0.040 |
Why?
|
Fetus | 1 | 2019 | 105 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 400 | 0.040 |
Why?
|
Registries | 1 | 2020 | 335 | 0.040 |
Why?
|
Emotions | 1 | 2020 | 220 | 0.040 |
Why?
|
Sexual Partners | 1 | 2021 | 314 | 0.040 |
Why?
|
Body Mass Index | 1 | 2021 | 854 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2020 | 276 | 0.040 |
Why?
|
Poverty | 1 | 2020 | 348 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2020 | 935 | 0.040 |
Why?
|
Risk | 1 | 2016 | 267 | 0.030 |
Why?
|
Absenteeism | 1 | 2015 | 11 | 0.030 |
Why?
|
Texas | 1 | 2016 | 324 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2020 | 560 | 0.030 |
Why?
|
Sex Distribution | 1 | 2015 | 215 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 333 | 0.030 |
Why?
|
Genotype | 1 | 2016 | 730 | 0.030 |
Why?
|
Needs Assessment | 1 | 2015 | 170 | 0.030 |
Why?
|
SEER Program | 1 | 2014 | 91 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 208 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 628 | 0.030 |
Why?
|
Survival Rate | 1 | 2014 | 311 | 0.030 |
Why?
|
Missouri | 1 | 2012 | 7 | 0.030 |
Why?
|
Live Birth | 1 | 2012 | 8 | 0.030 |
Why?
|
Maternal Age | 1 | 2012 | 26 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 767 | 0.030 |
Why?
|
Pregnancy in Adolescence | 1 | 2012 | 32 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 739 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2014 | 974 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 1492 | 0.020 |
Why?
|
Models, Biological | 1 | 2010 | 677 | 0.020 |
Why?
|
Animals | 1 | 2021 | 15081 | 0.020 |
Why?
|